Expression of EGFR-mutant proteins and genomic evolution in EGFR-mutant transformed small cell lung cancer

BACKGROUND: The transformation of epidermal growth factor receptor (EGFR)-mutant lung adenocarcinoma (LUAD) into small cell lung cancer (SCLC) accounts for 3–14% of the resistance mechanism to EGFR tyrosine kinase inhibitors (TKIs). At present, there is no relevant research to explore the dynamic ex...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Shi-Ling, Zhang, Chan-Yuan, Chen, Yu-Qing, Li, Yu-Fa, Xie, Zhi, Zhang, Xu-Chao, Zhou, Qing, Zhong, Wen-Zhao, Huang, Jie, Sun, Hao, Zheng, Ming-Ying, Xiao, Fa-Man, Yan, Hong-Hong, Lu, Dan-Xia, Lv, Zhi-Yi, Wu, Yi-Long, Chen, Hua-Jun, Yang, Jin-Ji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10586967/
https://www.ncbi.nlm.nih.gov/pubmed/37868836
http://dx.doi.org/10.21037/jtd-23-161

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10586967/
https://www.ncbi.nlm.nih.gov/pubmed/37868836
http://dx.doi.org/10.21037/jtd-23-161

Ejemplares similares